← All trials
NCT06509139
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 9, 2024
- Primary completion
- Jul 31, 2032
- Completion date
- Jul 31, 2032
- First posted
- Jul 19, 2024
- Last posted
- Nov 7, 2024
- Enrollment
- 661
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Cheng Kung UniversityLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.